De-risking the Nonclinical Safety Package for Vector Delivered Gene Therapies

Time: 9:45 am
day: Day One

Details:

  •  Evaluate current perspectives on safety risks for gene therapies
  • Delve into approaches & strategies to de-risking
  • Case study: species specific toxicities to high doses of human proteins

Speakers: